Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnitine complex (Godex) in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease
KCT0000505Phase 4Completed
- Sponsor
- Celltrion Pharm
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Godex in metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), sponsored by Celltrion Pharm. Started Sep 2011; status: completed.
02
Drugs
Godex
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0000505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000505.